DEBRA GAUTHIER: Open Payments
NPI 1679808695 · GEORGETOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 66 payments from 11 companies in 2025. Trend: 2023 $758 · 2024 $691 · 2025 $1,112
Food & beverage: $1,013Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $279 |
| ABBVIE INC. | 23 | $226 |
| Amgen Inc. | 14 | $186 |
| Janssen Biotech, Inc. | 7 | $142 |
| UCB, Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| LEO Pharma Inc. | 2 | $36 |
| Incyte Corporation | 1 | $28 |
| ConvaTec Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: DUPIXENT, OTEZLA, RINVOQ, TREMFYA, Bimzelx, SKYRIZI, COSENTYX, ADBRY.
Industry payments across TX — which companies pay providers there.
